2 chapters across the catalog
Pfizer Cannabis Acquisition, Cannabinoid Research
Pfizer acquires Arena Pharmaceuticals for $6.7 billion, a company focused on cannabinoid therapeutics, shortly after a study suggests cannabinoids can block SARS-CoV-2 entry. John C. Dvorak notes the popularity of CBD products among elderly women for treating arthritis.
Lorcaserin Weight Loss Drug, Arena Pharmaceuticals
Arena Pharmaceuticals is developing Lorcaserin, a new oral drug for weight management currently in Phase 3 clinical trials known as BLOOM and BLOSSOM. The drug targets obesity through behavioral modification and chemical intervention. Skepticism is expressed regarding the long-term safety of such weight-loss pills, noting a history of similar drugs being found deadly after release.
